Skip to content
Wenlo
Sign in
← Markets

CG Oncology Inc.

Leonard E Post (Director) sells CGON shares

4CGONFiled Nov 17, 2026, 11:30 AM ET· Period Nov 16, 2026

About this filing

CG Oncology Inc. (CGON) filed Form 4 (insider transaction) with the SEC on Nov 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Leonard E Post · Director

Rule 10b5-1 plan · adopted Mar 5, 2026

DateTransactionSharesPriceValueHeld afterOwnership
Nov 16, 2026M · exercise or conversion of a derivative+1,000$0.60$600.001,000Direct
Nov 16, 2026S · open-market saleFootnotes F1−1,000$92.00$92,000.001,000Direct
Nov 16, 2026M · exercise or conversion of a derivativeDirector Stock Option (right to buy)Footnotes F2−1,000$0.00$0.00101,077Direct
Footnotes
  1. F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026.
  2. F2 Fully vested

More CGON filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.